0.65
+0.0008(+0.12%)
Currency In USD
| Previous Close | 0.65 |
| Open | 0.64 |
| Day High | 0.66 |
| Day Low | 0.63 |
| 52-Week High | 6.17 |
| 52-Week Low | 0.36 |
| Volume | 214,530 |
| Average Volume | 11.2M |
| Market Cap | 7.86M |
| PE | -0.31 |
| EPS | -2.07 |
| Moving Average 50 Days | 0.62 |
| Moving Average 200 Days | 1.37 |
| Change | 0 |
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
GlobeNewswire Inc.
Jun 23, 2025 11:52 AM GMT
A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025 NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical
Impact Biomedical Inc. Announcement Stock Activity/Pricing
GlobeNewswire Inc.
Mar 21, 2025 6:38 PM GMT
HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that there has been no
Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room Air Quality”
GlobeNewswire Inc.
Feb 26, 2025 1:30 PM GMT
HOUSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced the acquisition of Celio